Selected research
Market Outlook & Growth Opportunities
Global Gleevec Market Outlook and Growth Opportunities 2026
Market perspective
The global Gleevec market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Gleevec is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Gleevec is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gleevec is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Gleevec market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Gleevec market include Novartis. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Gleevec market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Gleevec and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Gleevec sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gleevec market size, projected growth trends, production technologies, key applications, and end-use industries.
Gleevec Segment by Company
Novartis
Gleevec Segment by Type
400mg
100mg
Gleevec Segment by Application
Hospital
Pharmacy
Gleevec Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Gleevec status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Gleevec market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Gleevec significant trends, drivers, influence factors in global and regions.
6. To analyze Gleevec competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gleevec market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gleevec and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gleevec.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Gleevec market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gleevec industry.
Chapter 3: Detailed analysis of Gleevec manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Gleevec in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Gleevec in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 400mg
- 100mg
Applications
- Hospital
- Pharmacy
Companies covered
- Novartis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Gleevec Sales Value (2021-2032)
- 1.2.2 Global Gleevec Sales Volume (2021-2032)
- 1.2.3 Global Gleevec Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Gleevec Market Dynamics
- 2.1 Gleevec Industry Trends
- 2.2 Gleevec Industry Drivers
- 2.3 Gleevec Industry Opportunities and Challenges
- 2.4 Gleevec Industry Restraints
3 Gleevec Market by Company
- 3.1 Global Gleevec Company Revenue Ranking in 2025
- 3.2 Global Gleevec Revenue by Company (2021-2026)
- 3.3 Global Gleevec Sales Volume by Company (2021-2026)
- 3.4 Global Gleevec Average Price by Company (2021-2026)
- 3.5 Global Gleevec Company Ranking (2024-2026)
- 3.6 Global Gleevec Company Manufacturing Base and Headquarters
- 3.7 Global Gleevec Company Product Type and Application
- 3.8 Global Gleevec Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Gleevec Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Gleevec Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Gleevec Market by Type
- 4.1 Gleevec Type Introduction
- 4.1.1 400mg
- 4.1.2 100mg
- 4.2 Global Gleevec Sales Volume by Type
- 4.2.1 Global Gleevec Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Gleevec Sales Volume by Type (2021-2032)
- 4.2.3 Global Gleevec Sales Volume Share by Type (2021-2032)
- 4.3 Global Gleevec Sales Value by Type
- 4.3.1 Global Gleevec Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Gleevec Sales Value by Type (2021-2032)
- 4.3.3 Global Gleevec Sales Value Share by Type (2021-2032)
5 Gleevec Market by Application
- 5.1 Gleevec Application Introduction
- 5.1.1 Hospital
- 5.1.2 Pharmacy
- 5.2 Global Gleevec Sales Volume by Application
- 5.2.1 Global Gleevec Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Gleevec Sales Volume by Application (2021-2032)
- 5.2.3 Global Gleevec Sales Volume Share by Application (2021-2032)
- 5.3 Global Gleevec Sales Value by Application
- 5.3.1 Global Gleevec Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Gleevec Sales Value by Application (2021-2032)
- 5.3.3 Global Gleevec Sales Value Share by Application (2021-2032)
6 Gleevec Regional Sales and Value Analysis
- 6.1 Global Gleevec Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Gleevec Sales by Region (2021-2032)
- 6.2.1 Global Gleevec Sales by Region: 2021-2026
- 6.2.2 Global Gleevec Sales by Region (2027-2032)
- 6.3 Global Gleevec Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Gleevec Sales Value by Region (2021-2032)
- 6.4.1 Global Gleevec Sales Value by Region: 2021-2026
- 6.4.2 Global Gleevec Sales Value by Region (2027-2032)
- 6.5 Global Gleevec Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Gleevec Sales Value (2021-2032)
- 6.6.2 North America Gleevec Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Gleevec Sales Value (2021-2032)
- 6.7.2 Europe Gleevec Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Gleevec Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Gleevec Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Gleevec Sales Value (2021-2032)
- 6.9.2 South America Gleevec Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Gleevec Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Gleevec Sales Value Share by Country, 2025 VS 2032
7 Gleevec Country-level Sales and Value Analysis
- 7.1 Global Gleevec Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Gleevec Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Gleevec Sales by Country (2021-2032)
- 7.3.1 Global Gleevec Sales by Country (2021-2026)
- 7.3.2 Global Gleevec Sales by Country (2027-2032)
- 7.4 Global Gleevec Sales Value by Country (2021-2032)
- 7.4.1 Global Gleevec Sales Value by Country (2021-2026)
- 7.4.2 Global Gleevec Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Gleevec Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Gleevec Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Gleevec Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Gleevec Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Gleevec Sales Value Growth Rate (2021-2032)
- 7.9.2 France Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Gleevec Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Gleevec Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Gleevec Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Gleevec Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Gleevec Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Gleevec Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Gleevec Sales Value Growth Rate (2021-2032)
- 7.16.2 China Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Gleevec Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Gleevec Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Gleevec Sales Value Growth Rate (2021-2032)
- 7.19.2 India Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Gleevec Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Gleevec Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Gleevec Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Gleevec Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Gleevec Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Gleevec Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Gleevec Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Gleevec Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Gleevec Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Gleevec Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Gleevec Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Gleevec Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Gleevec Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Gleevec Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Gleevec Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Gleevec Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Novartis
- 8.1.1 Novartis Company Information
- 8.1.2 Novartis Business Overview
- 8.1.3 Novartis Gleevec Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Novartis Gleevec Product Portfolio
- 8.1.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Gleevec Value Chain Analysis
- 9.1.1 Gleevec Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Gleevec Sales Mode & Process
- 9.2 Gleevec Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Gleevec Distributors
- 9.2.3 Gleevec Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst